B.C. researchers launching clinical trial for first genetically engineered stem cell-based therapy for type 1 diabetes

Researchers from the University of British Columbia and Vancouver Coastal Health (VCH) have received $1 million from Canada’s Stem Cell Network to conduct research and a clinical trial for one of the world’s first genetically engineered cell replacement therapies for type 1 diabetes.

The researchers say the study is an important step toward developing a potential functional cure for type 1 diabetes.

Link to full story